Back to Search
Start Over
Protective role of a tmprss2 variant on severe covid-19 outcome in young males and elderly women
- Source :
- Genes, Vol 12, Iss 596, p 596 (2021), Genes (Basel) (2021)., info:cnr-pdr/source/autori:Monticelli, M.; Hay Mele, B.; Benetti, E.; Fallerini, C.; Baldassarri, M.; Furini, S.; Frullanti, E.; Mari, F.; GEN-COVID Multicenter Study; Andreotti, G.; Cubellis, M.V.; Renieri, A./titolo:Protective Role of a TMPRSS2 Variant on Severe COVID-19 Outcome in Young Males and Elderly Women/doi:/rivista:Genes (Basel)/anno:2021/pagina_da:/pagina_a:/intervallo_pagine:/volume, Genes
- Publication Year :
- 2021
-
Abstract
- The protease encoded by the TMPRSS2 gene facilitates viral infections and has been implicated in the pathogenesis of SARS-CoV-2. We analyzed the TMPRSS2 sequence and correlated the protein variants with the clinical features of a cohort of 1177 patients affected by COVID-19 in Italy. Nine relatively common variants (allele frequency > 0.01) and six missense variants which may affect the protease activity according to PolyPhen-2 in HumVar-trained mode were identified. Among them, p.V197M (p.Val197Met) (rs12329760) emerges as a common variant that has a deleterious effect on the protease and a protective effect on the patients. Its role appears particularly relevant in two subgroups of patients—young males and elderly women—and among those affected by co-morbidities, where the variant frequency is higher among individuals who were mildly affected by the disease and did not need hospitalization or oxygen therapy than among those more severely affected, who required oxygen therapy, ventilation or intubation. This study provides useful information for the identification of patients at risk of developing a severe form of COVID-19, and encourages the usage of drugs affecting the expression of TMPRSS2 or inhibiting protein activity.
- Subjects :
- 0301 basic medicine
Male
COVID19
medicine.medical_treatment
Disease
V197M
Comorbidity
QH426-470
Pathogenesis
0302 clinical medicine
Gene Frequency
Missense mutation
COVID-19
TMPRSS2
Whole-Exome Sequencing (WES)
Genetics (clinical)
Communication
Respiration
Serine Endopeptidases
Single Nucleotide
Middle Aged
3. Good health
Hospitalization
Serine Endopeptidase
Treatment Outcome
Italy
030220 oncology & carcinogenesis
Cohort
Artificial
Female
Aged
Humans
Mutation
Respiration, Artificial
Polymorphism, Single Nucleotide
Human
V179M
03 medical and health sciences
medicine
Genetics
Polymorphism
Allele frequency
Protease
business.industry
medicine.disease
030104 developmental biology
Immunology
business
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Genes, Vol 12, Iss 596, p 596 (2021), Genes (Basel) (2021)., info:cnr-pdr/source/autori:Monticelli, M.; Hay Mele, B.; Benetti, E.; Fallerini, C.; Baldassarri, M.; Furini, S.; Frullanti, E.; Mari, F.; GEN-COVID Multicenter Study; Andreotti, G.; Cubellis, M.V.; Renieri, A./titolo:Protective Role of a TMPRSS2 Variant on Severe COVID-19 Outcome in Young Males and Elderly Women/doi:/rivista:Genes (Basel)/anno:2021/pagina_da:/pagina_a:/intervallo_pagine:/volume, Genes
- Accession number :
- edsair.doi.dedup.....b8a5c9d0307595b1465203ef53a82f68